Future Prospects of Global Laboratory Proficiency Testing Market

The steady rise in narcotic analgesic sales is mostly due to the development of tolerance for non-narcotic analgesics. Narcotic analgesics are commonly utilised in palliative care services to treat patients suffering from neuropathic pain due to their better efficacy in pain control and early beginning of action. Increased attention on palliative care services in third-world nations, as well as readily available reimbursements, are predicted to raise global narcotic analgesic consumption.
Furthermore,
several government initiatives in low- and middle-income nations to provide
palliative care for the effective treatment of patients suffering from
excruciating cancer pain are driving up demand for narcotic analgesics as pain
medication in these countries.
The demand
for Narcotic
Analgesics Market in the United States is being driven by
reimbursements for post-operative care and palliative care. The reimbursement
scenario for wound care and wound management treatment is driving up narcotic
analgesic drug consumption. Supportive insurance policies for chemotherapy
cycles and post-operative care in developing nations are likely to drive global
demand for narcotic analgesics.
Narcostics Analgesics Market |
Market Drivers for Narcotics and
Analgesics
During the
foreseeable period, an increase in research for narcotic analgesics medications
is expected to boost the global market's growth. For example, Loma Linda
University is conducting a phase III clinical trial for the medication Narco.
The study's goal is to assess patient pain levels in the immediate
post-operative period and quantify pain medication use in patients who have
outpatient ENT surgery. The research began in February 2018 and is expected to
be completed in January 2019.
Furthermore,
Temple University is conducting a clinical phase II trial with AstraZeneca to
determine the impact of opioids on esophageal motility. Chronic opioid users
have esophageal motor impairment, according to the research. The safety and
tolerability of MOVANTIK (Naloxegol) will be investigated in this trial, which
is expected to alleviate opioid-induced esophageal motility problems. The
research began in January 2017 and will be completed in January 2020.
Restraint in the Narcotics Analgesics
Market
Shortages of
narcotic analgesics drugs are anticipated to have an impact on the market's
growth. According to the Drug Enforcement Administration (DEA) of the United
States, a number of injectable opioid drugs, such as morphine, hydromorphone,
and fentanyl, are currently experiencing serious shortages in the United
States. Patients undergoing interventional procedures such as heart
catheterization and surgery require injectable opioids to manage their pain.
Because opioid analgesics are particularly potent in pain control, a decrease
in supply of these vital medications can result in less effective pain control
for patients.
Comments
Post a Comment